The expression of phosphorylated MLC2 and myosin light chain kinase (MLCK) was significantly elevated in the CRS group, with these molecular changes also being ameliorated by Pcpa treatment (Fig. 3I), indicating the potential of 5-HT synthesis inhibition in maintaining tight junction integrity. The gene discussed is MYL2; the disease is congenital rubella syndrome.